Finn's laboratory combines basic research and clinical investigation, focusing on translational research in the area of atherosclerotic coronary artery disease, including mechanisms of disease, treatment, and exposing potential treatment complications. Currently, his research focuses on three major areas: 1) the effect of drug eluting stents on re-endothelialization of stent surfaces, particularly molecular mechanisms of vascular healing after injury; 2) the role of angiogenesis and intraplaque hemorrhage in coronary plaque progression and inflammation; and 3) the pathophysiology of coronary lesion progression in type 2 diabetics. The Finn lab makes use of both animal models and clinical trials to provide insights into mechanisms of disease and treatment which can be translated directly into the care of patients.
The Yoon Lab has been working on stem cell research in various cardiovascular diseases. Our major research interest is to use stem cell technology to treat various cardiovascular diseases, and we have been developing and using different bone marrow-derived stem sell or progenitor cells for cardiovascular repair.